CompletedNot Applicable

Lung and Breast Cancer Prevention by an Integrated Intervention of Maternal Smoking Cessation and Breastfeeding

United States40 participantsStarted 2021-01-01

Plain-language summary

This pilot clinical trial aims to integrate maternal smoking cessation and breastfeeding interventions to enhance both cancer prevention behaviors. The investigators will recruit 40 daily smoking women in their early pregnancy and randomize them into the integrated intervention or control group. Main outcomes include smoking abstinence and breastfeeding rates at 6 months postpartum.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Be 18 years or older * At ≤28 weeks of pregnancy * Daily smoking cigarettes and/or cigars in the past 7 days * Be able to read, listen, and talk in English Exclusion Criteria: * Being diagnosed with cancer * Current heavy drinking (more than 2 drinks a day) * Current use of illicit substances * Medical conditions contraindicating breastfeeding such as HIV infection, active tuberculosis, and breast removal

What they're measuring

Number of Participants With Smoking Abstinence

Timeframe: 6 months postpartum

Number of Participants With Reported Intent to Breastfeed

Timeframe: 35 weeks of pregnancy (the end of pregnancy)

Number of Participants Reporting to Breastfeed

Timeframe: 6 months postpartum

Trial details

NCT IDNCT05123118

SponsorXiaozhong Wen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-10-30

Results submitted2025-03-17

View on ClinicalTrials.gov More Smoking, Cigarette trials